Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34339501)
Watch
English
Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
3622394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589709%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
title
Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer
(English)
1 reference
stated in
Europe PubMed Central
PMCID
3622394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589709%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
main subject
prostate cancer
1 reference
based on heuristic
inferred from title
author
Emmanuel S Antonarakis
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
3622394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589709%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
author name string
Ali R Golshayan
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
3622394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589709%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
language of work or name
English
0 references
publication date
4 April 2013
1 reference
stated in
Europe PubMed Central
PMCID
3622394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589709%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
published in
Core Evidence
1 reference
stated in
Europe PubMed Central
PMCID
3622394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589709%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
volume
8
1 reference
stated in
Europe PubMed Central
PMCID
3622394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589709%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
page(s)
27-35
1 reference
stated in
Europe PubMed Central
PMCID
3622394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589709%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
copyright license
Creative Commons Attribution-NonCommercial 3.0 Unported
start time
1 April 2013
1 reference
stated in
April 2022 Public Data File from Crossref
copyright status
copyrighted
0 references
cites work
Abiraterone in metastatic prostate cancer without previous chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Increased survival with enzalutamide in prostate cancer after chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
ARN-509: a novel antiandrogen for prostate cancer treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Cancer statistics, 2012
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Abiraterone and increased survival in metastatic prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Sipuleucel-T immunotherapy for castration-resistant prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Development of a second-generation antiandrogen for treatment of advanced prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
6 July 2018
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
27 October 2018
Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
27 October 2018
A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
27 October 2018
The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622394
retrieved
27 October 2018
Identifiers
DOI
10.2147/CE.S34747
1 reference
stated in
Europe PubMed Central
PMCID
3622394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589709%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
PMCID
3622394
1 reference
stated in
Europe PubMed Central
PMCID
3622394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589709%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
PubMed ID
23589709
1 reference
stated in
Europe PubMed Central
PMCID
3622394
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23589709%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
